SCHEMBL19909482

SCHEMBL19909482

N#Cc1cc(-n2c3ccccc3c3ccc(-c4ccccc4)cc32)c(-c2ccncc2)cc1-n1c2ccccc2c2ccc(-c3ccccc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.41
SQOR Q9Y6N5 1/20 0.40
GSK3B P49841 2/20 0.40
PRKACA P17612 1/20 0.40
CDK8 P49336 1/20 0.40
CLK2 P49760 1/20 0.40
GSK3A P49840 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
PRKCQ Q04759 1/20 0.40
ROCK1 Q13464 1/20 0.40
DYRK1A Q13627 1/20 0.40
LRRK2 Q5S007 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
PIK3CA P42336 1/20 0.39
MEN1 O00255 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909463 0.98 IMPDH2 (0.42) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19913331 0.94 SQOR (0.40) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL20923088 0.94 PIK3CA (0.41) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19919781 0.93 FLT3 (0.39) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19913201 0.93 IMPDH2 (0.41) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19909483 0.93 PIK3CA (0.41) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19909158 0.92 SQOR (0.38) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19913129 0.92 ALDH1A1 (0.38) IMPDH2SQORGSK3BPRKACACDK8
SCHEMBL19919616 0.91 CYP1A2 (0.40) SQORGSK3BGSK3AROCK1CLK4
SCHEMBL19909296 0.91 PIK3CA (0.43) IMPDH2SQORGSK3BPRKACACDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 IMPDH2 2305/4885SQOR 1580/4885GSK3B 3022/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 IMPDH2 2305/4885SQOR 1580/4885GSK3B 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.